Increased levels of vascular endothelial growth factor and interleukin-6 in the aqueous humor of diabetics with macular edema

被引:306
作者
Funatsu, H
Yamashita, H
Noma, H
Mimura, T
Yamashita, T
Hori, S
机构
[1] Tokyo Womens Med Univ, Ctr Diabet, Dept Ophthalmol, Shinjuku Ku, Tokyo 1628666, Japan
[2] Yamagata Univ, Sch Med, Dept Ophthalmol, Yamagata 99023, Japan
[3] Hiroshima Univ, Sch Med, Dept Ophthalmol, Hiroshima, Japan
关键词
D O I
10.1016/S0002-9394(01)01269-7
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE: To investigate the relationship between diabetic macular edema and the levels of vascular endo. thelial growth factor VEGF) and interleukin 6 (IL-6) in aqueous humor and plasma. DESIGN: Comparative cross-sectional study. METHODS: Fifty,four eyes from 54 diabetic patients were used. The concentrations of VEGF and IL-6 in undiluted aqueous specimens (obtained from the eyes during cataract surgery) and in plasma were measured by an enzyme-linked immunosorbent assay. To assess bloods aqueous barrier function, the aqueous flare intensity was measured by a laser flare,cell meter as an estimate of the aqueous protein level. RESULTS: The aqueous levels of VEGF and IL-6 were significantly correlated with the severity of macular edema (P = 0.628, P <.001 and p = 0.517, P <.01 respectively), as well as with the aqueous protein concentration (p = 0.618, P <.001 and p = 0.588, P <.001, respectively). Aqueous levels of VEGF and IL-6 were significantly higher than their respective plasma levels (both P <.001). In addition, the aqueous level of VEGF was significantly correlated with that of IL-6 (p = 0.537, P <.01). Furthermore, the status of the posterior vitreous significantly correlated with the severity of macular edema (1) = 0.618, P <.000 1). CONCLUSIONS: These results suggest that both VEGF and IL-6 are produced together in the intraocular tissues, and are involved in the pathogenesis of macular edema.
引用
收藏
页码:70 / 77
页数:8
相关论文
共 62 条
[41]  
LEWIS H, 1992, OPHTHALMOLOGY, V99, P753
[42]  
LIMB G A, 1991, Eye (London), V5, P686
[43]   Localization of vascular endothelial growth factor in human retina and choroid [J].
Lutty, GA ;
McLeod, DS ;
Merges, C ;
Diggs, A ;
Plouet, J .
ARCHIVES OF OPHTHALMOLOGY, 1996, 114 (08) :971-977
[44]   IL-6 INCREASES ENDOTHELIAL PERMEABILITY INVITRO [J].
MARUO, N ;
MORITA, I ;
SHIRAO, M ;
MUROTA, SI .
ENDOCRINOLOGY, 1992, 131 (02) :710-714
[45]   STUDIES OF THE BLOOD-AQUEOUS BARRIER IN DIABETES-MELLITUS [J].
MORIARTY, AP ;
SPALTON, DJ ;
MORIARTY, BJ ;
SHILLING, JS ;
FFYTCHE, TJ ;
BULSARA, M .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1994, 117 (06) :768-771
[46]   The 14-year incidence of visual loss in a diabetic population [J].
Moss, SE ;
Klein, R ;
Klein, BEK .
OPHTHALMOLOGY, 1998, 105 (06) :998-1003
[47]  
Murata T, 1996, LAB INVEST, V74, P819
[48]   VASCULAR ENDOTHELIAL GROWTH-FACTOR PLAYS A ROLE IN HYPERPERMEABILITY OF DIABETIC RETINAL-VESSELS [J].
MURATA, T ;
ISHIBASHI, T ;
KHALIL, A ;
HATA, Y ;
YOSHIKAWA, H ;
INOMATA, H .
OPHTHALMIC RESEARCH, 1995, 27 (01) :48-52
[49]  
MURRAY PI, 1990, INVEST OPHTH VIS SCI, V31, P917
[50]  
NASRALLAH FP, 1988, OPHTHALMOLOGY, V95, P1335